tm
Seeing Is Believing
tm
Seeing Is Believing
VINC is currently covered by 2 analysts
Vincerx Pharma's activity chart (see below) currently has 12 price targets and 13 ratings on display. The stock rating distribution of VINC is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 47.62% with an average time for these price targets to be met of 295.71 days.
Highest price target for VINC is $117, Lowest price target is $8.
Most recent stock forecast was given by JONATHAN CHANG from LEERINK on 08-Oct-2024. First documented stock forecast 13-Aug-2021.
Currently out of the existing stock ratings of VINC, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$2
$0.91 (83.49%)
2 years 20 days ago
(08-Oct-2024)
4/4 (100%)
$-6.16 (-75.49%)
166
Buy
$5
2 years 6 months 27 days ago
(01-Apr-2024)
2/2 (100%)
$-9.3 (-65.03%)
654
Buy
$4
$2.91 (266.97%)
$11
3 years 11 months 11 days ago
(17-Nov-2022)
4/4 (100%)
$-12.2 (-75.31%)
612
Buy
$6
$1.22 (25.52%)
$12
4 years 4 months 21 days ago
(07-Jun-2022)
1/3 (33.33%)
$4.03 (204.57%)
638
Buy
$30
4 years 6 months 24 days ago
(04-Apr-2022)
0/2 (0%)
$13.71 (84.35%)
What is VINC (Vincerx Pharma) average time for price targets to be met?
Which analyst most recently updated their price target on VINC (Vincerx Pharma)?
Which analyst has the current lower performing score on VINC (Vincerx Pharma) with a proven track record?
Which analyst has the most public recommendations on VINC (Vincerx Pharma)?
Which analyst is the currently most bullish on VINC (Vincerx Pharma)?
Which analyst is the currently most reserved on VINC (Vincerx Pharma)?
